INJECTION SITE MOVEMENT IMPAIRMENT

This adverse event was reported 128 times

These drugs are most commonly taken by patients reporting INJECTION SITE MOVEMENT IMPAIRMENT:

# Drug Count
0 NALTREXONE 21
1 EPINEPHRINE 8
2 GABAPENTIN 7
3 GLATIRAMER ACETATE 7
4 MONTELUKAST SODIUM 7
5 ACETAMINOPHEN 5
6 ACETAMINOPHEN 500MG 4
7 ACETAMINOPHEN TABLET EXTENDED RELEASE 4
8 DUPILUMAB 4
9 ONABOTULINUMTOXINA 4
See all common drugs associated with INJECTION SITE MOVEMENT IMPAIRMENT

INJECTION SITE MOVEMENT IMPAIRMENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LENACAPAVIR SODIUM 1 0.0020
1 SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE 1 0.0013
2 CABOTEGRAVIR SODIUM 2 0.0012
3 DANTROLENE SODIUM 1 0.0009
4 NALTREXONE 21 0.0007
5 ARIPIPRAZOLE LAUROXIL 3 0.0007
6 VORINOSTAT 1 0.0005
7 ROPIVACAINE HYDROCHLORIDE 1 0.0004
8 INCOBOTULINUMTOXINA 2 0.0003
9 RILPIVIRINE 2 0.0003
See all drugs enriched for association with INJECTION SITE MOVEMENT IMPAIRMENT